Antony Loebel's most recent trade in Seaport Therapeutics Inc. was a trade of 63,680 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seaport Therapeutics Inc | Antony Loebel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2026 | 63,680 | 63,680 | - | - | Stock Option (Right to Buy) | |
| Seaport Therapeutics Inc | Antony Loebel | Chief Medical Officer | 30 Apr 2026 | 63,157 | 0 | - | - | Series B Preferred Stock | ||
| Seaport Therapeutics Inc | Antony Loebel | Chief Medical Officer | 30 Apr 2026 | 20,109 | 20,109 | - | - | Common Stock |